Stocks · Health care · Pharmaceutical Preparations

Aquestive Therapeutics, Inc.

AQST Clue Score18
United States Fiscal year ends December CIK 0001398733 Results filed 3 Nov 2026

What the insiders did Balanced

Insider
Date
Role
Action
Shares
Price
Amount
Daniel Barber
15 Oct 2026
President and CEO
Sold on a plan
25,000
$4.22
$105.60K
Daniel Barber
15 Sep 2026
President and CEO
Sold on a plan
25,000
$4.82
$120.49K
Daniel Barber
17 Aug 2026
President and CEO
Sold on a plan
25,000
$4.29
$107.17K
Daniel Barber
16 Jul 2026
President and CEO
Sold on a plan
20,369
$4.00
$81.51K
Daniel Barber
15 Jul 2026
President and CEO
Sold on a plan
4,631
$4.03
$18.68K
Daniel Barber
15 Jun 2026
President and CEO
Sold on a plan
25,000
$4.16
$104.01K
Daniel Barber
15 May 2026
President and CEO
Sold on a plan
8,257
$4.29
$35.41K
Peter E. Boyd
15 Oct 2025
See Remarks
Sold on a plan
10,000
$7.00
$70.00K
Carl N Kraus
15 Oct 2025
Chief Medical Officer
Sold on a plan
20,272
$7.00
$141.90K
Peter E. Boyd
26 Sep 2025
See Remarks
Sold on a plan
10,000
$6.30
$63.00K
Daniel Barber
26 Sep 2025
President and CEO
Sold on a plan
91,343
$6.03
$551.19K
Daniel Barber
19 Sep 2025
President and CEO
Sold on a plan
400
$6.00
$2.40K
Peter E. Boyd
5 Sep 2025
See Remarks
Sold on a plan
15,000
$5.30
$79.50K
Alexander Mark Schobel
15 Mar 2024
Chief Innovation/Tech Officer
Sold on a plan
50,000
$6.00
$300.00K
Alexander Mark Schobel
8 Mar 2024
Chief Innovation/Tech Officer
Sold on a plan
25,000
$5.19
$129.69K

What was left out

Form 4 filings counted 284
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 4
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 11,746,136
Sales filed before the plan box existed 9
History held since 26 Jul 2018